Early Clinical Data Raise the Bar for Hemophilia Gene Therapies
October 11, 2016
Several gene therapy companies reported promising early clinical data in July showing that they could restore healthy blood clotting factor levels in people with severe hemophilia.
Continue reading here.
How a tissue-swelling method brought super-resolution imaging to the masses.
In response to cellular stress, proteins become ensnared in chemical traffic jams, creating a kind of widespread sluggishness scientists call “proteolethargy.”